Adult Dosing

Hypomagnesemia

• 140-280 mg PO tid
• Alt: 400-800 mg PO Daily

Antacid

• 140 mg PO tid-qid
• Alt: 400-840 mg PO Daily
• Max duration: 2 wks

Note:

• Take magnesium oxide and other medicine at least 2 hours apart

Pediatric Dosing

• Safety and efficacy in pediatric patients have not been established

[Outline]

• Adult Dosing
• Pediatric Dosing

• Treatment and prevention of hypomagnesemia
• Relief of heartburn, sour stomach, or acid indigestion

• Hypersensitivity to any of the ingredients of the product
• Ulcerative colitis
• Diverticulitis
• Colostomy or ileostomy

• N/A

Renal Dose Adjustment

• Renal impairment: Caution advised, dose adjustments not defined
• Renal failure: Avoid use

Hepatic Dose Adjustment

• Hepatic impairment: Dose adjustments not defined

Cautions: Use cautiously in

• Renal impairment
• Hepatic impairment
• Cardiac diseases
• Intestinal diseases

Pregnancy Category:B

Breastfeeding: Safety unknown

• GI: Diarrhea, nausea, vomiting
• METABOLIC: Hypermagnesemia
• DERM: Rash, itching, flushing, sweating
• MISC: Weakness

• Antacid; Neutralize the gastric acid, attracts/retains water in intestinal lumen and induce peristalsis, resulting in evacuation of colonic contents
• Not metabolized
• Renally excreted
• Half-life: unknown

US Trade Name(s)

• Only generic available

US Availability

magnesium oxide (generic)

• CAPS: 140 mg
• TABS: 400 mg

Canadian Trade Name(s)

• N/A

Canadian Availability

• N/A

UK Trade Name(s)

• N/A

UK Availability

• N/A

Australian Trade Name(s)

• N/A

Australian Availability

• N/A

[Outline]

Gastrointestinal

Antacids

Nutrition/Electrolytes

Minerals & Electrolytes

Drug Name: Magmilax 276000 MG Oral Tablet

Ingredient(s): Magnesium Oxide

Imprint: 2

Color(s): Pink

Shape: Oval

Size (mm): 8.00

Score: 2

Inactive Ingredient(s): N/A

Drug Label Author:
Sparhawk Laboratories, Inc.

DEA Schedule:
Non-Scheduled